IndraLab

Statements


Mutated EGFR activates STAT3. 20 / 20
| 20

reach
"EGFR mutations may decrease the number of CD8+ cells, elevate the Treg population, and activate the STAT-3 intracellular pathway, leading to immune escape and increased resistance to targeted drugs (82)."

reach
"Greulich et al. reported that STAT3 was activated by various EGFR mutations, including the exon 19 in-frame deletion or the exon 21 L858R point mutation, and may contribute to the oncogenic effects of these mutations in fibroblasts and human lung cancer cells [XREF_BIBR]."

reach
"The mechanism whereby mutant EGFR drives STAT3 activation is indirect, as it requires upregulation of the cytokine IL-6, which activated the gp130 and JAK pathway [XREF_BIBR] (XREF_FIG)."

reach
"The mutant EGFR could activate signal transducer and activator of transcription -3 (STAT3) pathway via interleukin-6 upregulation in primary human lung cancer leading to cancer progression (Gao et al., 2007; Wang et al., 2013)."

reach
"For example, acylglycerol kinase potentiates JAK2 and STAT3 signaling in ESCC XREF_BIBR; Epstein-Barr virus (EBV)-encoded proteins constitutively activated STAT3 in NPC XREF_BIBR, XREF_BIBR; and, EGFR mutation mediates STAT3 activation via IL-6 production in lung cancer XREF_BIBR."

reach
"EGFR mutations activate ERK, AKT and STAT3 directly or through IL-6-JAK2 [XREF_BIBR, XREF_BIBR, XREF_BIBR]."

reach
"Activation mutations of EGFR have been reported to activate STAT3, which is required for the oncogenic effects of EGFR mutations [XREF_BIBR, XREF_BIBR]."

reach
"NCI-H1650 is a lung adenocarcinoma cell, in which a mutant EGFR regulates the expression of the IL-6 cytokine and leads to the activation of JAK and STAT3 pathway."

reach
"EGFR mutations cause abnormal activation of the downstream JAK/STAT3 signalling pathway, leading to the expression of increased phosphorylated STAT3, and hence abnormal tumor proliferation, angiogenesis, invasion, and metastasis."

reach
"EGFR mutations activate phosphatidylinositol 3-kinase (PI3K)/AKT, Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3), but less so Ras and mitogen activated protein kinase (MAPK)."

reach
"EGFR mutations cause abnormal activation of the downstream JAK/STAT3 signalling pathway, leading to increased expression of phosphorylated STAT3, followed by abnormal tumor growth, angiogenesis, invasion, and metastasis."

reach
"Stat3 is activated by mutant EGFR and JAK, and notably, pStat3 is associated with tumor cell proliferation and angiogenesis [XREF_BIBR]."

reach
"EGFR mutations activate MAPK, PI3K-AKT, and STAT3 directly or through IL-6-JAK2 (5,10,21)."

reach
"Human lung cancer cell lines with activating EGFR mutations have shown marked STAT3 activation; however, targeting EGFR mutations can not effectively inhibit STAT3 activation."

reach
"Previous findings have shown that EGFR mutations activate STAT3 (55)."

reach
"Our results also suggest that while activating mutations of EGFR may enhance IL-6 production and autocrine stimulation of STAT3 activity, additional cellular factors are important in modulating this pathway and the response of cells to IL6."

reach
"Although STAT3 is activated by EGFR mutations [XREF_BIBR, XREF_BIBR], other receptor and non receptor tyrosine kinases such as the interleukin-6 (IL-6)/gp130 receptor can also stimulate STAT3 activation [XREF_BIBR]."

reach
"Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells."

reach
"It was also noted that EGFR mutant lung cancer cell lines selectively activate AKT and STAT3 signaling pathways, promoting cell survival."

reach
"EGFR mutations activated Akt, ERK, and STAT3 to promote cell survival."